top of page

Engineering Tregs To Restore Balance In Inflammatory Disorders

Bastion Therapeutics' HQ has officially closed. After a challenging and rewarding journey over the past 2 years, we’ve made the difficult decision to close our doors. Our lab has been emptied, and the team is unfortunately having to move on to new paths.

Our GRIT™ Platform for disease-specific therapy unleashes the multi-functional capabilities of regulatory T cells

Over 600 million people worldwide suffer from Inflammatory Disorders

Our goal is to provide curative therapies to transform the lives of patients

Holding hands

Bastion Therapeutics is rapidly advancing its early programmes towards the clinic

We are addressing the root cause of the disease by restoring balance to a dysregulated immune system

Balancing stones

Creating a future where inflammatory disorders are curable

Colleagues Working in Office

Our Leadership comprises seasoned scientists and business executives with diverse experience and expertise

Come help shape the future of cellular therapies here at Bastion Therapeutics

Science Lab

Laptop

Follow our news section for Bastion Therapeutics' latest developments and upcoming events

Bastion Therapeutics' HQ has officially closed. After a challenging and rewarding journey over the past 2 years, we’ve made the difficult decision to close our doors. Our lab has been emptied, and the team is unfortunately having to move on to new paths.

Bastion Therapeutics' HQ has officially closed. After a challenging and rewarding journey over the past 2 years, we’ve made the difficult decision to close our doors. Our lab has been emptied, and the team is unfortunately having to move on to new paths.

bottom of page